摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-hydroxy-3-(3-nitrophenyl)propionic acid | 184882-22-2

中文名称
——
中文别名
——
英文名称
2-hydroxy-3-(3-nitrophenyl)propionic acid
英文别名
2-Hydroxy-3-(3-nitrophenyl)propanoic acid
2-hydroxy-3-(3-nitrophenyl)propionic acid化学式
CAS
184882-22-2
化学式
C9H9NO5
mdl
——
分子量
211.174
InChiKey
GXAHXUKUJSHFEY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    438.7±30.0 °C(Predicted)
  • 密度:
    1.475±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-hydroxy-3-(3-nitrophenyl)propionic acid 在 5%-palladium/activated carbon 氢气 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以100%的产率得到(+/-)-2-hydroxy-3-(3-aminophenyl)propanoic acid
    参考文献:
    名称:
    Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field
    摘要:
    本发明涉及具有一般式(I)的化合物,其中R1和R2,可以相同也可以不同,选自包括-H或具有1至6个碳原子的直链或支链烷基基团,或者共同形成具有5或6个原子的芳香或脂肪环的群;Y和Z,可以相同也可以不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH的群,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,烯丙基和具有1至6个碳原子的直链或支链烷基基团。
    公开号:
    US20090048343A1
  • 作为产物:
    描述:
    (3-Nitro-phenyl)-brenztraubensaeuresodium hydroxide 、 sodium tetrahydroborate 作用下, 以79%的产率得到2-hydroxy-3-(3-nitrophenyl)propionic acid
    参考文献:
    名称:
    Deracemisation of aryl substituted α-hydroxy esters using Candida parapsilosis ATCC 7330: effect of substrate structure and mechanism
    摘要:
    Candida parapsilosis ATCC 7330 was found to be an efficient biocatalyst for the deracemisation of aryl alpha-hydroxy esters (65-85% yield and 90-99% ee). A variety of aryl and aryl substituted alpha-hydroxy esters were synthesized to reflect steric and electronic effects on biocatalytic deracemisation. The mechanism of this biocatalytic deracemisation was found to be stereoinversion. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2005.09.104
点击查看最新优质反应信息

文献信息

  • Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field
    申请人:Naccari Giancarlo
    公开号:US20090048343A1
    公开(公告)日:2009-02-19
    The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
    本发明涉及具有一般式(I)的化合物,其中R1和R2,可以相同也可以不同,选自包括-H或具有1至6个碳原子的直链或支链烷基基团,或者共同形成具有5或6个原子的芳香或脂肪环的群;Y和Z,可以相同也可以不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH的群,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,烯丙基和具有1至6个碳原子的直链或支链烷基基团。
  • Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
    申请人:Giuliani International Limited
    公开号:US08153841B2
    公开(公告)日:2012-04-10
    The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR3, —CH(OR3)COOH, in which R3 is selected from H, phenyl, benzyl, —CF3 or —CF2CF3, vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
    本发明涉及具有通式(I)的化合物,其中R1和R2可能相同或不同,选自包括-H或具有1至6个碳原子的线性或支链烷基或共同形成具有5或6个原子的芳香或脂肪环的群体; Y和Z可能相同或不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,丙烯基和具有1至6个碳原子的线性或支链烷基。
  • Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
    申请人:Naccari Giancarlo
    公开号:US20130005813A1
    公开(公告)日:2013-01-03
    The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
    本发明涉及通式(I)的化合物,其中R1和R2可以相同或不同,选自包括-H或具有1到6个碳原子的线性或支链烷基或共同形成具有5或6个原子的芳香或脂肪环的群体;Y和Z可以相同或不同,选自包括-H、-OH、-COOH、-OR3、-CH(OR3)COOH的群体,其中R3选自H、苯基、苄基、-CF3或-CF2CF3、乙烯基、丙烯基和具有1到6个碳原子的线性或支链烷基。
  • US8153841B2
    申请人:——
    公开号:US8153841B2
    公开(公告)日:2012-04-10
  • US8710100B2
    申请人:——
    公开号:US8710100B2
    公开(公告)日:2014-04-29
查看更多